Structure-Based High-Efficiency Homogeneous Antibody Platform by Endoglycosidase Sz Provides Insights into Its Transglycosylation Mechanism

• Yin-Cheng Hsieh,
• Hong-Hsiang Guan,
• Chien-Chih Lin,
• Teng-Yi Huang,
• Phimonphan Chuankhayan,
• Nai-Chi Chen,
• Nan-Hsuan Wang,
• Pu-Ling Hu,
• Yi-Chien Tsai,
• Yen-Chieh Huang,
• Masato Yoshimura,
• Pei-Ju Lin,
• Yih-Huang Hsieh,
• Chun-Jung Chen

Affiliations

Yin-Cheng Hsieh

OBI Pharma, Inc., Taipei City, Taiwan

Hong-Hsiang Guan

Life Science Group, Scientific Research Division, National Synchrotron Radiation Research Center, Hsinchu, Taiwan

Chien-Chih Lin

Life Science Group, Scientific Research Division, National Synchrotron Radiation Research Center, Hsinchu, Taiwan

Teng-Yi Huang

OBI Pharma, Inc., Taipei City, Taiwan

Phimonphan Chuankhayan

Life Science Group, Scientific Research Division, National Synchrotron Radiation Research Center, Hsinchu, Taiwan

Nai-Chi Chen

Life Science Group, Scientific Research Division, National Synchrotron Radiation Research Center, Hsinchu, Taiwan

Nan-Hsuan Wang

OBI Pharma, Inc., Taipei City, Taiwan

Pu-Ling Hu

OBI Pharma, Inc., Taipei City, Taiwan

Yi-Chien Tsai

OBI Pharma, Inc., Taipei City, Taiwan

Yen-Chieh Huang

Life Science Group, Scientific Research Division, National Synchrotron Radiation Research Center, Hsinchu, Taiwan

Masato Yoshimura

Life Science Group, Scientific Research Division, National Synchrotron Radiation Research Center, Hsinchu, Taiwan

Pei-Ju Lin

Life Science Group, Scientific Research Division, National Synchrotron Radiation Research Center, Hsinchu, Taiwan

Yih-Huang Hsieh

OBI Pharma, Inc., Taipei City, Taiwan

Chun-Jung Chen

Life Science Group, Scientific Research Division, National Synchrotron Radiation Research Center, Hsinchu, Taiwan